FISH

 
3627_4569
FISH
The detection of genetic aberrations in malignant tissues with DNA Fluorescence in situ Hybridization (FISH) probe technology is a powerful means to diagnose and more efficiently treat a wide range of cancers.  Abbott Molecular offers a comprehensive line of direct-labeled DNA probes for tumor assessment. Single and multi-color probe sets offer researchers and clinicians a variety of ways to identify chromosome or locus deletions, gains, or translocations that occur in cancers.  These probes can be applied to a variety of sample types prepared for metaphase or interphase analysis.